About Tekla Life Sciences Investors
https://www.teklacap.com/hql.htmlTekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe.
CEO
Daniel R. Omstead
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 2 of 2
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
SABA CAPITAL MANAGEMENT, L.P.
Shares:2.59M
Value:$43.61M
MORGAN STANLEY
Shares:870.66K
Value:$14.68M
PENSERRA CAPITAL MANAGEMENT LLC
Shares:794.14K
Value:$13.39M
Summary
Showing Top 3 of 104
About Tekla Life Sciences Investors
https://www.teklacap.com/hql.htmlTekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $18.2M ▲ | $0 ▼ | $-47.23M ▼ | -259.55% ▼ | $-1.64 ▼ | $-47.23M ▼ |
| Q4-2024 | $1.91M ▼ | $3.18M ▲ | $35.04M ▼ | 1.83K% ▼ | $1.22 ▼ | $0 ▼ |
| Q2-2024 | $2.07M ▼ | $2.72M ▼ | $50.26M ▲ | 2.43K% ▲ | $1.84 ▲ | $101.17M ▲ |
| Q4-2023 | $29.56M ▲ | $38.42M ▲ | $-11.45M ▼ | -38.73% ▼ | $-0.43 ▼ | $-11.45M ▼ |
| Q2-2023 | $1.93M | $2.87M | $33.8M | 1.75K% | $1.29 | $0 |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $75.54K ▼ | $515.38M ▲ | $1.73M ▼ | $513.66M ▲ |
| Q2-2025 | $12.16M ▲ | $411.34M ▼ | $15.4M ▲ | $395.94M ▼ |
| Q4-2024 | $0 | $460.58M ▲ | $888.61K ▲ | $459.69M ▲ |
| Q2-2024 | $0 ▼ | $441.95M ▲ | $879.91K ▲ | $441.07M ▲ |
| Q4-2023 | $15.24M | $402.6M | $666.96K | $401.93M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-47.23M ▼ | $-1.04M ▼ | $4.39M ▲ | $-8.41M ▼ | $0 ▼ | $-1.04M ▼ |
| Q4-2023 | $11.18M ▼ | $0 | $0 | $0 | $32 ▲ | $0 |
| Q2-2023 | $33.8M ▲ | $0 | $0 | $0 | $0 ▲ | $0 |
| Q4-2022 | $-52.3K | $0 | $0 | $0 | $-545 | $0 |
| Q2-2022 | $-52.3K | $0 | $0 | $0 | $-545 | $0 |
CEO
Daniel R. Omstead
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 2 of 2
Ratings Snapshot
Rating : C-
Price Target
Institutional Ownership
SABA CAPITAL MANAGEMENT, L.P.
Shares:2.59M
Value:$43.61M
MORGAN STANLEY
Shares:870.66K
Value:$14.68M
PENSERRA CAPITAL MANAGEMENT LLC
Shares:794.14K
Value:$13.39M
Summary
Showing Top 3 of 104